BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15893423)

  • 1. CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis.
    Wu ML; Li H; Wu DC; Wang XW; Chen XY; Kong QY; Ma JX; Gao Y; Liu J
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):33-7. PubMed ID: 15893423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells.
    Liu J; Wang Q; Wu DC; Wang XW; Sun Y; Chen XY; Zhang KL; Li H
    Neurosci Lett; 2004 Jun; 363(3):257-61. PubMed ID: 15182955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abundance of aryl hydrocarbon receptor potentiates benzo[a]pyrene-induced apoptosis in Hepa1c1c7 cells via CYP1A1 activation.
    Chung JY; Kim JY; Kim WR; Lee SG; Kim YJ; Park JE; Hong YP; Chun YJ; Park YC; Oh S; Yoo KS; Yoo YH; Kim JM
    Toxicology; 2007 Jun; 235(1-2):62-72. PubMed ID: 17433523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol.
    Ciolino HP; Yeh GC
    Mol Pharmacol; 1999 Oct; 56(4):760-7. PubMed ID: 10496959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas.
    Chang JT; Chang H; Chen PH; Lin SL; Lin P
    Clin Cancer Res; 2007 Jan; 13(1):38-45. PubMed ID: 17200336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzyl butyl phthalate induces necrosis by AhR mediation of CYP1B1 expression in human granulosa cells.
    Chen HS; Chiang PH; Wang YC; Kao MC; Shieh TH; Tsai CF; Tsai EM
    Reprod Toxicol; 2012 Jan; 33(1):67-75. PubMed ID: 22138065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig.
    Nannelli A; Rossignolo F; Tolando R; Rossato P; Longo V; Gervasi PG
    Toxicology; 2009 Nov; 265(3):69-79. PubMed ID: 19786062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.
    Macpherson L; Matthews J
    Cancer Lett; 2010 Dec; 299(2):119-29. PubMed ID: 20846786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
    Chen ZH; Hurh YJ; Na HK; Kim JH; Chun YJ; Kim DH; Kang KS; Cho MH; Surh YJ
    Carcinogenesis; 2004 Oct; 25(10):2005-13. PubMed ID: 15142886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CYP1A1 expression is involved in unresponsiveness of the human hepatoma cell line SK-HEP-1 to dioxin.
    Shiizaki K; Ohsako S; Koyama T; Nagata R; Yonemoto J; Tohyama C
    Toxicol Lett; 2005 Dec; 160(1):22-33. PubMed ID: 16054781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression.
    Do MT; Kim HG; Tran TT; Khanal T; Choi JH; Chung YC; Jeong TC; Jeong HG
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):138-48. PubMed ID: 25110054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue.
    Yang X; Solomon S; Fraser LR; Trombino AF; Liu D; Sonenshein GE; Hestermann EV; Sherr DH
    J Cell Biochem; 2008 May; 104(2):402-17. PubMed ID: 18059014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells.
    Spink DC; Katz BH; Hussain MM; Pentecost BT; Cao Z; Spink BC
    Carcinogenesis; 2003 Dec; 24(12):1941-50. PubMed ID: 12970067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.
    Stejskalova L; Vecerova L; Peréz LM; Vrzal R; Dvorak Z; Nachtigal P; Pavek P
    Toxicol Sci; 2011 Sep; 123(1):26-36. PubMed ID: 21666223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain transcriptomics in response to beta-naphthoflavone treatment in rainbow trout: the role of aryl hydrocarbon receptor signaling.
    Aluru N; Vijayan MM
    Aquat Toxicol; 2008 Apr; 87(1):1-12. PubMed ID: 18282621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
    Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
    Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
    Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
    Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.